Pictet Asset Management’s Ascendis Pharma A/S ASND Stock Holding History

Pictet Asset Management’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$62.3M	Sell	234,039 -17,794	-7%	-$4.16M	0.06%	296
2026 Q1	$56.9M	Buy	251,833 +178,415	+243%	+$40M	0.06%	290
2025 Q4	$15.5M	Sell	73,418 -3,640	-5%	-$752K	0.02%	580
2025 Q3	$14.8M	Sell	77,058 -8,480	-10%	-$1.58M	0.01%	593
2025 Q2	$14.7M	Sell	85,538 -21,220	-20%	-$3.46M	0.02%	581
2025 Q1	$16.5M	Sell	106,758 -37,441	-26%	-$5.35M	0.02%	542
2024 Q4	$19.9M	Sell	144,199 -9,845	-6%	-$1.29M	0.02%	505
2024 Q3	$22.3M	Buy	154,044 +7,717	+5%	+$1.04M	0.02%	466
2024 Q2	$20M	Sell	146,327 -124,443	-46%	-$16.9M	0.02%	465
2024 Q1	$40.9M	Buy	270,770 +67,116	+33%	+$9.58M	0.04%	347
2023 Q4	$25.7M	Buy	203,654 +32,784	+19%	+$3.27M	0.03%	419
2023 Q3	$16M	Buy	+170,870	New	+$16M	0.02%	520

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Pictet Asset Management's ASND Position: Q2 2026 in Review

Pictet Asset Management reduced its Ascendis Pharma A/S (ASND) stake by 7.1% in Q2 2026, selling an estimated $4.16M and leaving 234,039 shares worth $62.3M. The position accounts for 0.06% of the portfolio, ranked #296.

Pictet Asset Management first reported a position in ASND in Q3 2023 and has held it in 12 quarters since. 313 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

Pictet Asset Management held 234,039 shares of Ascendis Pharma A/S worth $62.3M as of Q2 2026.
Pictet Asset Management sold 17,794 Ascendis Pharma A/S shares in Q2 2026, an estimated $4.16M.
Ascendis Pharma A/S made up 0.06% of Pictet Asset Management's portfolio in Q2 2026, its #296 holding.
Pictet Asset Management first reported a position in Ascendis Pharma A/S in Q3 2023 and has held it in 12 quarters since.
313 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.